Allogene Therapeutics, Inc. earnings per share and revenue

ALLO earnings per share for the last quarter are -0.35 USD whereas the estimation was -0.35 USD which accounts for -0.01% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 2.01 M USD. Estimated earnings per share for the next quarter are -0.33 USD, and revenue is expected to reach 10.77 k USD. Also watch annual changes over time to get a bigger picture of ALLO earnings per share and revenue dynamics.